HKUMed identifies PLK4 as a promising therapeutic target for TP53 mutated AML, demonstrated in Queen Mary Hospital and other studies
A research team led by Professor Anskar Leung Yu-hung, from the Department of Medicine, School of Clinical Medicine, LKS Faculty ...